RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million

🌐 Investing.com (CY) —
RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million

AI Summary

RegenLab announced plans for a Nasdaq listing under the ticker RGNA after surpassing $29 million in revenues. The company's move to go public marks a significant development in its financial growth and visibility in the biotech sector.

Markets Deals Health AI & Tech RegenLab Nasdaq listing biotech revenues Cyprus

Read original source →